Clinical Trial Update: The Evaluation of Oral Acitretin in the Treatment of Psoriasis, Cutaneous Disorders of Keratinization, Multiple Basal Cell Carcinomas and Other Retinoid Responsive Diseases

View source ↗

Summary

This clinical trial evaluated oral acitretin for psoriasis, cutaneous keratinization disorders, and multiple basal cell carcinomas; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Basal Cell Carcinoma
• Keratosis Palmaris Et Plantaris
• Psoriasis

Drugs mentioned

• Acitretin (Acitretin)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Basal Cell Carcinoma, Keratosis Palmaris et Plantaris | Status: COMPLETED